Thrombomodulin as a marker of vascular and lymphatic tumours

M. A C Appleton, R. L. Attanoos, B. Jasani

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The aim of this study was to evaluate the utility of a new commercially available antibody to thrombomodulin as an endothelial marker in formalin-fixed paraffin-embedded tissue. The expression of thrombomodulin in a variety of 50 vascular and lymphatic neoplasms and malformations was compared to the expression of von Willebrand factor, QBend 10 (CD34) and JC70 (CD31). We showed that thrombomodulin was the best marker of lymphatic endothelium and also stained a higher percentage of malignant vasoformative tumours when compared to the other markers. We recommend the assessment of thrombomodulin expression in the differential diagnosis of malignant vasoformative neoplasms and in the detection of lymphatic endothelium for evidence of tumour permeation.

Original languageEnglish
Pages (from-to)153-157
Number of pages5
JournalHistopathology
Volume29
Issue number2
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Thrombomodulin
Blood Vessels
Lymphatic Endothelium
Neoplasms
Vascular Neoplasms
Vascular Malformations
von Willebrand Factor
Paraffin
Formaldehyde
Differential Diagnosis
Antibodies

Keywords

  • CD31
  • CD34
  • Thrombomodulin
  • Vascular tumours
  • von Willebrand factor

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Appleton, M. A. C., Attanoos, R. L., & Jasani, B. (1996). Thrombomodulin as a marker of vascular and lymphatic tumours. Histopathology, 29(2), 153-157.

Thrombomodulin as a marker of vascular and lymphatic tumours. / Appleton, M. A C; Attanoos, R. L.; Jasani, B.

In: Histopathology, Vol. 29, No. 2, 1996, p. 153-157.

Research output: Contribution to journalArticle

Appleton, MAC, Attanoos, RL & Jasani, B 1996, 'Thrombomodulin as a marker of vascular and lymphatic tumours', Histopathology, vol. 29, no. 2, pp. 153-157.
Appleton MAC, Attanoos RL, Jasani B. Thrombomodulin as a marker of vascular and lymphatic tumours. Histopathology. 1996;29(2):153-157.
Appleton, M. A C ; Attanoos, R. L. ; Jasani, B. / Thrombomodulin as a marker of vascular and lymphatic tumours. In: Histopathology. 1996 ; Vol. 29, No. 2. pp. 153-157.
@article{4e3a138906f4489e84fe2b22765b5d67,
title = "Thrombomodulin as a marker of vascular and lymphatic tumours",
abstract = "The aim of this study was to evaluate the utility of a new commercially available antibody to thrombomodulin as an endothelial marker in formalin-fixed paraffin-embedded tissue. The expression of thrombomodulin in a variety of 50 vascular and lymphatic neoplasms and malformations was compared to the expression of von Willebrand factor, QBend 10 (CD34) and JC70 (CD31). We showed that thrombomodulin was the best marker of lymphatic endothelium and also stained a higher percentage of malignant vasoformative tumours when compared to the other markers. We recommend the assessment of thrombomodulin expression in the differential diagnosis of malignant vasoformative neoplasms and in the detection of lymphatic endothelium for evidence of tumour permeation.",
keywords = "CD31, CD34, Thrombomodulin, Vascular tumours, von Willebrand factor",
author = "Appleton, {M. A C} and Attanoos, {R. L.} and B. Jasani",
year = "1996",
language = "English",
volume = "29",
pages = "153--157",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley Blackwell",
number = "2",

}

TY - JOUR

T1 - Thrombomodulin as a marker of vascular and lymphatic tumours

AU - Appleton, M. A C

AU - Attanoos, R. L.

AU - Jasani, B.

PY - 1996

Y1 - 1996

N2 - The aim of this study was to evaluate the utility of a new commercially available antibody to thrombomodulin as an endothelial marker in formalin-fixed paraffin-embedded tissue. The expression of thrombomodulin in a variety of 50 vascular and lymphatic neoplasms and malformations was compared to the expression of von Willebrand factor, QBend 10 (CD34) and JC70 (CD31). We showed that thrombomodulin was the best marker of lymphatic endothelium and also stained a higher percentage of malignant vasoformative tumours when compared to the other markers. We recommend the assessment of thrombomodulin expression in the differential diagnosis of malignant vasoformative neoplasms and in the detection of lymphatic endothelium for evidence of tumour permeation.

AB - The aim of this study was to evaluate the utility of a new commercially available antibody to thrombomodulin as an endothelial marker in formalin-fixed paraffin-embedded tissue. The expression of thrombomodulin in a variety of 50 vascular and lymphatic neoplasms and malformations was compared to the expression of von Willebrand factor, QBend 10 (CD34) and JC70 (CD31). We showed that thrombomodulin was the best marker of lymphatic endothelium and also stained a higher percentage of malignant vasoformative tumours when compared to the other markers. We recommend the assessment of thrombomodulin expression in the differential diagnosis of malignant vasoformative neoplasms and in the detection of lymphatic endothelium for evidence of tumour permeation.

KW - CD31

KW - CD34

KW - Thrombomodulin

KW - Vascular tumours

KW - von Willebrand factor

UR - http://www.scopus.com/inward/record.url?scp=0029812951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029812951&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 153

EP - 157

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 2

ER -